Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer.
Ji T, Gong D, Han Z, Wei X, Yan Y, Ye F, Ding W, Wang J, Xia X, Li F, Hu W, Lu Y, Wang S, Zhou J, Ma D, Gao Q.
Ji T, et al. Among authors: gong d.
Cancer Lett. 2013 Dec 1;341(2):231-9. doi: 10.1016/j.canlet.2013.08.022. Epub 2013 Aug 17.
Cancer Lett. 2013.
PMID: 23962558